Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP implementation demonstration project for high-risk youth in Wuhan and Guangzhou
CTR20210725Phase 4Active
- Sponsor
- Patheon
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Patheon. Started Sep 2021; status: active.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20210725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210725.